Numerali Life Sciences

Numerali is an AI-native biotechnology company dedicated to unlocking the "dark proteome"—the vast portion of the human proteome that remains uncharacterized and undrugged. By integrating advanced machine learning with high-throughput experimental biology, the company aims to discover novel small molecule therapeutics for previously inaccessible targets. Their platform leverages proprietary datasets and computational models to predict protein-ligand interactions with high precision. Numerali focuses on therapeutic areas with high unmet needs, including oncology and immunology. The company is headquartered in San Francisco and was founded by veterans of the AI-biotech industry.